Copy
View this email in your browser
Share Share
Tweet Tweet
Forward Forward
Multiple Sclerosis News Today's Daily Digest
The Web's Daily Resource for Multiple Sclerosis News

In the 08/18/2021 edition:

MS News Today podcast: Interview with Gretchen Hawley

Jenn chats with Gretchen Hawley, a Doctor of Physical Therapy, and a Multiple Sclerosis Certified Specialist. Dr. Hawley utilizes the concept of neuroplasticity to help her clients reduce fatigue, get stronger, improve their balance, and walk better. Listen in as Dr. Gretchen shares practical and helpful tips and suggestions on how everyone with MS can benefit from specifically catered physical therapy.
Listen Now

Collaboration Explores Therapies for Autoimmune Diseases

By Marta Figueiredo PhD on Aug 18, 2021 07:00 am

autoimmune diseasesCytocom has joined forces with La Jolla Institute for Immunology (LJI) to discover and develop new immune-modulating therapies targeting toll-like receptors (TLRs) for autoimmune diseases such as multiple sclerosis (MS), cancer, and infectious and chronic inflammatory conditions. TLRs are an important family of protein receptors found at the surface of immune cells and others; they play […]

The post Collaboration Explores Therapies for Autoimmune Diseases appeared first on Multiple Sclerosis News Today.

Continue Reading

Trial Will Test Ocrevus on Arm, Hand Function in PPMS

By Marisa Wexler MS on Aug 18, 2021 07:00 am

Ocrevus and PPMSA Phase 3 clinical trial testing the effect of Ocrevus (ocrelizumab) on upper limb disability progression in people with primary progressive multiple sclerosis (PPMS) is recruiting participants. The trial, called O’HAND (NCT04035005), expects to enroll approximately 1,000 adults with PPMS, ages 18 to 65, at more than 200 sites around the world. A full list […]

The post Trial Will Test Ocrevus on Arm, Hand Function in PPMS appeared first on Multiple Sclerosis News Today.

Continue Reading

Recent Articles:

Probiotics Likely To Be of Help With RRMS, Meta-analysis Finds
Ocrevus Effective in RRMS Patients With Poor Responses to Prior DMTs
MS News That Caught My Eye Last Week: Mavenclad, Sativex, Mistreatment, Patient Survey
‘Personal Zen’ Mobile App Helps to Ease Anxiety in Pediatric-onset MS
Lemtrada Does Not Lead to Brain Bleeds, Small Belgian Study Says
Read the Latest News, Patient Columns, HCP content, and Patient Forums
Listen to our Flash briefings, available here:
Discuss these topics and much more on the MS News Today forums
Join Now
Follow us on social Media for access to exclusive content!
Twitter
Facebook
Instagram
SoundCloud
LinkedIn
Pinterest

Copyright © 2021 BioNews Inc., All rights reserved.



Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.